Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

April 16, 2024

Study Completion Date

April 16, 2024

Conditions
Pseudophakia
Interventions
DIAGNOSTIC_TEST

Visual Acuity

Measurement of distance, intermediate and near visual acuity.

DIAGNOSTIC_TEST

Defocus Curve

Measurement of visual acuity performed from +1.00 to -4.00 in 0.50 diopter steps and with +0.25 and -0.25 added.

DIAGNOSTIC_TEST

Halo and Glare testing

Measurement to quantify degree of visual loss caused by either halo and/or glare.

OTHER

Patient Questionnaires

Patients will complete a series of questionnaires to record self-reported visual disturbances, visual acuity satisfaction, level of spectacle independence and any issues with glare, halos, and/or starbursts.

Trial Locations (1)

77027

Berkeley Eye Center, Houston

All Listed Sponsors
lead

Berkeley Eye Center

OTHER